SYDNEY (Reuters) - Australia's corporate regulator said the local arm of Goldman Sachs has agreed to review how it sells shares to investors, after it failed to notify the market about dwindling interest in a block trade it conducted for Healthscope in 2015.
The Australian Securities and Investments Commission (ASIC) said Goldman Sachs Australia had failed to tell investors that interest for the A$853 million ($628.66 million) block trade in shares of the health operator had waned.
"Investors need to have confidence that they are being provided with accurate information in the course of a bookbuild or underwriting process," ASIC Commissioner Cathie Armour said in a statement on Monday.
($1 = 1.3569 Australian dollars)
(Reporting by Byron Kaye and Paulina Duran; Editing by Himani Sarkar)
Disclaimer: No Business Standard Journalist was involved in creation of this content
